Article thumbnail

Exploring the mechanisms of renoprotection against progressive glomerulosclerosis

By Takashi OITE

Abstract

In this review, I introduce the strategy developed by our laboratory to explore the mechanisms of renoprotection against progressive glomerulosclerosis leading to renal death. First, I describe the experimental rat model in which disturbances of vascular regeneration and glomerular hemodynamics lead to irreversible glomerulosclerosis. Second, I discuss the possible mechanisms determining the progression of glomerulosclerosis and introduce a new imaging system based on intravital confocal laser scanning microscopy. Third, I provide an in-depth review of the regulatory glomerular hemodynamics at the cellular and molecular levels while focusing on the pivotal role of Ca2+-dependent gap junctional intercellular communication in coordinating the behavior of mesangial cells. Last, I show that local delivery of renoprotective agents, in combination with diagnostic imaging of the renal microvasculature, allows the evaluation of the therapeutic effects of angiotensin II receptor and cyclooxygenase activity local blockade on the progression of glomerulosclerosis, which would otherwise lead to renal death

Topics: Review
Publisher: The Japan Academy
OAI identifier: oai:pubmedcentral.nih.gov:3066542
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1996). A specific Thy-1 molecular epitope expressed on rat mesangial cells.
  2. (2010). accepted
  3. (2003). Additive effect of ACE inhibition and angiotensin II receptor blocker in type I diabetic nephropathy.
  4. (2008). An overview of regular dialysis treatment
  5. (2000). Are selective COX-2 inhibitors nephrotoxic?
  6. (2003). ATP-dependent mechanisms for coordination of intercellular Ca2D signaling and renin secretion in rat juxtaglomerular cells.
  7. (2006). Bone marrow cell infusion ameliorates progressive glomerulosclerosis in an experimental rat model.
  8. (2005). Bone marrow cells contribute to regeneration of glomerular endothelial cells.
  9. (2006). Calcium wave of tubuloglomerular feedback.
  10. (1998). Comparative nephritogenicity of two monoclonal antibodies of rat Thy-1.1 molecule.
  11. (2002). Coordination of mesangial cell contraction by gap junction—mediated intercellular Ca2D wave.
  12. (1994). Cyclooxigenase-2 is associated with the macula densa of rat kidney and increases with salt restriction.
  13. (2001). Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide.
  14. (2010). Diabetic CKD/ESRD 2010: a progress report?
  15. (1983). Distribution of glomeruli in the renal cortex of Munich Wistar Fromter (MWF) rats.
  16. (2009). Disturbance of glomerular hemodynamics: a risk factor determining progression of glomerular diseases?
  17. (2001). Effects of all-trans retinoic acid on reninangiotensin system in rats with experimental nephritis.
  18. (2001). for the Collaborative Study Group
  19. (1997). Green mice’ as a source of ubiquitous green cells.
  20. He obtained Doctor of Philosophy (Ph.D.) in 1979. The title of thesis is “Masugi nephritis in T cell depleted state. Influence of adult thymectomy and anti-thymocyte serum”.
  21. (2000). Hemodynamics.
  22. (1981). Hyperfiltration in Remnant nephrons: a potentially adverse response to renal ablation.
  23. (2002). Impairment of vascular regeneration proceeds progressive glomerulosclerosis in anti-Thy-1 glomerulonephritis.
  24. (1981). Intraglomerular microcirculation: measurements of single glomerular loop flow in rats.
  25. (2010). Local delivery of angiotensin II receptor blockers into the kidney passively attenuates inflammatory reactions during the early phases of streptozotoci-induced diabetic nephropathy through inhibition of calpain activity.
  26. (2006). Local delivery of angiotensin receptor blocker into the kidney Renoprotection against progressive glomerulosclerosis No. 3] 89ameliorates progression of experimental glomerulonephritis.
  27. (2010). Macula densa sensing and signaling mechanisms of renin release.
  28. (2002). Maintenance dialysis population dynamics: current trends and long-term implication.
  29. (1997). Pathophysiology of progressive renal disease.
  30. (2001). Real time observation of hemodynamic changes in glomerular aneurysms induced by antiThy-1 antibody.
  31. (2004). Real-time observation of glomerular hemodynamic changes in diabetic rats: effects of insulin and ARB.
  32. (1987). Reduced glomerular angiotensin II receptor density in diabetes mellitus in the rat: time course and mechanism.
  33. (2001). Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in rat.
  34. (2002). Remission of renal disease: recounting the challenge, acquiring the goal.
  35. (1997). Renoprotection and reninangiotensin system blockade in diabetes mellitus.
  36. (2000). Requirement for PI3-kinase in PDGF-induced disruption of gap junctional intercellular communication and phosphorylation of connexin 43 in mesangial cells.
  37. (2002). Selective cyclooxygenase-2 inhibition impairs glomerular capillary healing in experimental glomerulonephritis.
  38. (2010). Selective deletion of connexin 40 in renin-producing cells impairs renal baroreceptor function and is associated with arterial hypertension.
  39. (2005). Strategies for improving longterm survival in patients with ESRD.
  40. (1996). studied as a scholarship holder of Alexander von Humboldt foundation, with Professor Arnold VOGT, in Freiburg, West Germany (1979–1981). He was promoted to Professor and Director at the
  41. (2004). The characterization of a specific Thy-1 molecular epitope expressed on rat mesangial cells.
  42. (1993). The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
  43. (2006). Turbulence of glomerular hemodynamics involved in progressive glomerulosclerosis.